Caris Life Sciences (CAI) Inventory (2024 - 2026)

Caris Life Sciences' Inventory history runs 3 years deep, the most recent figure standing at $76.3 million for Q1 2026.

• In Q1 2026, Inventory changed N/A year-over-year to $76.3 million; the TTM figure through Mar 2026 stood at $76.3 million (changed N/A YoY), while the FY2025 annual figure was $63.6 million, up 60.78% from the prior year.
• Inventory for Q1 2026 stood at $76.3 million, up from $63.6 million in the prior quarter.
• The five-year high for Inventory was $76.3 million in Q1 2026, with the low at $39.6 million in Q4 2024.
• The 3-year median for Inventory is $49.3 million (2025), against an average of $53.9 million.
• Peak annual rise in Inventory reached 60.78% in 2025, while the deepest fall reached 60.78% in 2025.
• Caris Life Sciences' Inventory stood at $39.6 million in 2024, then soared by 60.78% to $63.6 million in 2025, then advanced by 19.9% to $76.3 million in 2026.
• Business Quant data shows CAI's Inventory at $76.3 million in Q1 2026, $63.6 million in Q4 2025, and $49.3 million in Q3 2025.